Finance

Beta
Lists
EDSA:NASDAQ
Edesa Biotech Inc
၇.၀၁ US$
-၀.၁၄%
(-၀.၀၁၀၀) 1D
ဇူ ၁၀, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EDSA...
Open
၆.၉၁ US$
High
၇.၂၄ US$
Low
၆.၉၁ US$
Mkt. cap
၆.၂၃ ကုဋေ
Avg. vol.
၂.၀၇ သိန်း
Volume
၅.၀၆ သောင်း
52-wk high
၂၀.၃၂ US$
52-wk low
၀.၇၂ US$
EPS
-၁.၃၄ US$
Beta
၁.၀၃
Shares outstanding
၉.၆၃ သန်း
No. of employees
၁၇
Open
၆.၉၁ US$
High
၇.၂၄ US$
Low
၆.၉၁ US$
Mkt. cap
၆.၂၃ ကုဋေ
Avg. vol.
၂.၀၇ သိန်း
Volume
၅.၀၆ သောင်း
52-wk high
၂၀.၃၂ US$
52-wk low
၀.၇၂ US$
EPS
-၁.၃၄ US$
Beta
၁.၀၃
Shares outstanding
၉.၆၃ သန်း
No. of employees
၁၇
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
JD.com (NasdaqGS:JD) Faces 618 Advertising Scrutiny As Pomerantz Opens Securities Investigation
富途牛牛
富途牛牛
·
ပြီးခဲ့သည့် ၇ မိနစ်
Dow Jones Top Company Headlines at 7 PM ET: Apple Sues OpenAI, Alleging It Stole Trade Secrets | SK ...
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၄၀ မိနစ်
FIGX Capital Acquisition Corp. (NASDAQ:FIGX) Sees Large Decline in Short Interest
CNBC
CNBC
·
ပြီးခဲ့သည့် ၉ နာရီ
SK Hynix rises 13% in Nasdaq debut. Chairman tells CNBC 'demand is enormous'
About Edesa Biotech Inc
CEO-
Employees၁၇
Founded၂၀၀၇
Headquartersမာက်ဟမ်း, အွန်တေးရီးယိုးပြည်နယ်, ကနေဒါ
Sector-
Websiteedesabiotech.com
Analyst ratings
Based on 1 analyst giving stock ratings to EDSA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for EDSA in the last 3 months
Highest
Current ၇.၀၁ US$
၂၁.၀၀ US$ (+၁၉၉.၅၇%)
Average
၂၁.၀၀ US$ (+၁၉၉.၅၇%)
Lowest
၂၁.၀၀ US$ (+၁၉၉.၅၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kumaraguru Raja
Brookline Capital Markets
Buy
Initiated
၂၁.၀၀ US$
+၁၉၉.၆%
06/29/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
၅.၀၀ US$
-၂၈.၇%
11/03/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၉.၃၉ သိန်း
၁.၂၃ သန်း
၁.၁၂ သန်း
၂.၇၇ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉.၆၅ သိန်း
၁.၂၄ သန်း
၁.၂၂ သန်း
၁.၅၃ သန်း
Operating expense
၁.၉၀ သန်း
၂.၄၇ သန်း
၂.၃၄ သန်း
၄.၃၀ သန်း
Total operating expenses
၁.၉၀ သန်း
၂.၄၇ သန်း
၂.၃၄ သန်း
၄.၃၀ သန်း
Operating income
-၁.၉၀ သန်း
-၂.၄၇ သန်း
-၂.၃၄ သန်း
-၄.၃၀ သန်း
Other non operating income
-
-
-
၆.၆၂ သောင်း
EBT including unusual items
-၁.၇၅ သန်း
-၂.၂၃ သန်း
-၂.၂၅ သန်း
-၄.၂၂ သန်း
EBT excluding unusual items
-၁.၉၃ သန်း
-၂.၄၈ သန်း
-၂.၃၅ သန်း
-၄.၂၂ သန်း
Income tax expense
-
-
-
၈၀၀.၀၀
Effective tax rate
-
-
-
-၀.၀၂%
Other operating expenses
-
-
-
-
Net income
-၁.၇၅ သန်း
-၂.၂၃ သန်း
-၂.၂၅ သန်း
-၄.၂၂ သန်း
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
၅၇၂.၀၀
၅၅.၀၀
၄၇.၀၀
၆၃၉.၀၀
Interest expense
-
-
-
-
Net interest expenses
၅၇၂.၀၀
၅၅.၀၀
၄၇.၀၀
၆၃၉.၀၀
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၈၈ သန်း
-၂.၄၄ သန်း
-၂.၃၂ သန်း
-၄.၂၇ သန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer